Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
Bug, G, Burchert, A, Wagner, E-M, Kröger, N, Berg, T, Güller, S, Metzelder, S K, Wolf, A, Hünecke, S, Bader, P, Schetelig, J, Serve, H, Ottmann, O GLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2017.242
Date:
July, 2017
File:
PDF, 769 KB
english, 2017
File converter
More search results
More benefits 
